GLG Partners’s Global Cord Blood Corporation CO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$6.35M Sell
638,136
-30,687
-5% -$336K 0.3% 107
2017
Q3
$7.44M Sell
668,823
-841,490
-56% -$9.85M 0.39% 78
2017
Q2
$14.3M Sell
1,510,313
-96,855
-6% -$773K 0.79% 34
2017
Q1
$10.7M Sell
1,607,168
-1,220
-0.1% -$7.23K 0.5% 63
2016
Q4
$9.84M Buy
1,608,388
+577,518
+56% +$2.88M 0.39% 67
2016
Q3
$5.27M Buy
1,030,870
+106,939
+12% +$570K 0.16% 165
2016
Q2
$5.31M Buy
923,931
+19,800
+2% +$121K 0.16% 179
2016
Q1
$5.49M Buy
904,131
+136,669
+18% +$816K 0.16% 164
2015
Q4
$4.89M Buy
767,462
+562,529
+274% +$3.55M 0.16% 159
2015
Q3
$1.23M Buy
+204,933
New +$1.27M 0.03% 330

Other funds holding CO

GLG Partners's CO Position: Q4 2017 in Review

GLG Partners reduced its Global Cord Blood Corporation (CO) stake by 4.6% in Q4 2017, selling an estimated $336K and leaving 638,136 shares worth $6.35M. The position accounts for 0.3% of the portfolio, ranked #107.

GLG Partners first reported a position in CO in Q3 2015 and has held it in 10 quarters since. The position peaked at $14.3M in Q2 2017. 50 funds tracked by Wall St. Rank hold CO as of Q4 2017.

  • GLG Partners held 638,136 shares of Global Cord Blood Corporation worth $6.35M as of Q4 2017.
  • GLG Partners sold 30,687 Global Cord Blood Corporation shares in Q4 2017, an estimated $336K.
  • Global Cord Blood Corporation made up 0.3% of GLG Partners's portfolio in Q4 2017, its #107 holding.
  • GLG Partners first reported a position in Global Cord Blood Corporation in Q3 2015 and has held it in 10 quarters since.
  • GLG Partners's Global Cord Blood Corporation position peaked at $14.3M in Q2 2017.
  • 50 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q4 2017.

Based on GLG Partners's 13F filing for Q4 2017, filed 14 Feb 2018.